1. Home
  2. BCAB vs ATON Comparison

BCAB vs ATON Comparison

Compare BCAB & ATON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • ATON
  • Stock Information
  • Founded
  • BCAB 2007
  • ATON 1973
  • Country
  • BCAB United States
  • ATON British Virgin Islands
  • Employees
  • BCAB N/A
  • ATON N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • ATON Oil & Gas Production
  • Sector
  • BCAB Health Care
  • ATON Energy
  • Exchange
  • BCAB Nasdaq
  • ATON Nasdaq
  • Market Cap
  • BCAB 40.5M
  • ATON 37.1M
  • IPO Year
  • BCAB 2020
  • ATON N/A
  • Fundamental
  • Price
  • BCAB $0.76
  • ATON $5.13
  • Analyst Decision
  • BCAB Hold
  • ATON
  • Analyst Count
  • BCAB 3
  • ATON 0
  • Target Price
  • BCAB $1.00
  • ATON N/A
  • AVG Volume (30 Days)
  • BCAB 1.4M
  • ATON 2.4M
  • Earning Date
  • BCAB 11-05-2025
  • ATON 11-25-2025
  • Dividend Yield
  • BCAB N/A
  • ATON N/A
  • EPS Growth
  • BCAB N/A
  • ATON N/A
  • EPS
  • BCAB N/A
  • ATON N/A
  • Revenue
  • BCAB $11,000,000.00
  • ATON N/A
  • Revenue This Year
  • BCAB N/A
  • ATON N/A
  • Revenue Next Year
  • BCAB N/A
  • ATON N/A
  • P/E Ratio
  • BCAB N/A
  • ATON N/A
  • Revenue Growth
  • BCAB N/A
  • ATON N/A
  • 52 Week Low
  • BCAB $0.24
  • ATON $2.95
  • 52 Week High
  • BCAB $2.53
  • ATON $15.82
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 52.28
  • ATON N/A
  • Support Level
  • BCAB $0.61
  • ATON N/A
  • Resistance Level
  • BCAB $1.06
  • ATON N/A
  • Average True Range (ATR)
  • BCAB 0.13
  • ATON 0.00
  • MACD
  • BCAB -0.02
  • ATON 0.00
  • Stochastic Oscillator
  • BCAB 32.78
  • ATON 0.00

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About ATON AlphaTON Capital Corp. Common Stock

AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.

Share on Social Networks: